Retinal Pigment Epithelium Expressed Toll-like Receptors and Their Potential Role in Age-Related Macular Degeneration

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Aug 27

PMID 34445096

Citations 14

Authors

Alexa Klettner

Johann Roider

Affiliations

Soon will be listed here.

Abstract

(1) Background: Inflammation is a major pathomechanism in the development and progression of age-related macular degeneration (AMD). The retinal pigment epithelium (RPE) may contribute to retinal inflammation via activation of its Toll-like receptors (TLR). TLR are pattern recognition receptors that detect the pathogen- or danger-associated molecular pattern. The involvement of TLR activation in AMD is so far not understood. (2) Methods: We performed a systematic literature research, consulting the National Library of Medicine (PubMed). (3) Results: We identified 106 studies, of which 54 were included in this review. Based on these studies, the current status of TLR in AMD, the effects of TLR in RPE activation and of the interaction of TLR activated RPE with monocytic cells are given, and the potential of TLR activation in RPE as part of the AMD development is discussed. (4) Conclusion: The activation of TLR2, -3, and -4 induces a profound pro-inflammatory response in the RPE that may contribute to (long-term) inflammation by induction of pro-inflammatory cytokines, reducing RPE function and causing RPE cell degeneration, thereby potentially constantly providing new TLR ligands, which could perpetuate and, in the long run, exacerbate the inflammatory response, which may contribute to AMD development. Furthermore, the combined activation of RPE and microglia may exacerbate neurotoxic effects.

Citing Articles

Cellular Senescence: An Emerging Player in the Pathogenesis of AMD.

Wagh V, Damodaren N, Mittal S, Cardenas-Diaz F, Sun H, Loktev A Adv Exp Med Biol. 2025; 1468:33-37.

PMID: 39930169 DOI: 10.1007/978-3-031-76550-6_6.

Gallic Acid-Encapsulated PAMAM Dendrimers as an Antioxidant Delivery System for Controlled Release and Reduced Cytotoxicity against ARPE-19 Cells.

Sripunya A, Chittasupho C, Mangmool S, Angerhofer A, Imaram W Bioconjug Chem. 2024; 35(12):1959-1969.

PMID: 39641479 PMC: 11660146. DOI: 10.1021/acs.bioconjchem.4c00475.

TLR2 and TLR4 Are Expressed in Epiretinal Membranes: Possible Links with Vitreous Levels of Complement Fragments and DAMP-Related Proteins.

Dinice L, Esposito G, Cacciamani A, Balzamino B, Cosimi P, Cafiero C Int J Mol Sci. 2024; 25(14).

PMID: 39062973 PMC: 11276880. DOI: 10.3390/ijms25147732.

Effects of Fucoidans on Activated Retinal Microglia.

Dorschmann P, Hunger F, Schroth H, Chen S, Kopplin G, Roider J Int J Mol Sci. 2024; 25(11).

PMID: 38892206 PMC: 11173224. DOI: 10.3390/ijms25116018.

The mouse retinal pigment epithelium mounts an innate immune defense response following retinal detachment.

Abcouwer S, Scavuzzi B, Kish P, Kong D, Shanmugam S, Le X J Neuroinflammation. 2024; 21(1):74.

PMID: 38528525 PMC: 10964713. DOI: 10.1186/s12974-024-03062-2.

References

Zareparsi S, Buraczynska M, Branham K, Shah S, Eng D, Li M . Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet. 2005; 14(11):1449-55. DOI: 10.1093/hmg/ddi154. View

Karlstetter M, Scholz R, Rutar M, Wong W, Provis J, Langmann T . Retinal microglia: just bystander or target for therapy?. Prog Retin Eye Res. 2014; 45:30-57. DOI: 10.1016/j.preteyeres.2014.11.004. View

Feng L, Ju M, Lee K, Mackey A, Evangelista M, Iwata D . A Proinflammatory Function of Toll-Like Receptor 2 in the Retinal Pigment Epithelium as a Novel Target for Reducing Choroidal Neovascularization in Age-Related Macular Degeneration. Am J Pathol. 2017; 187(10):2208-2221. PMC: 5809578. DOI: 10.1016/j.ajpath.2017.06.015. View

Tode J, Richert E, Koinzer S, Klettner A, von der Burchard C, Brinkmann R . Thermal Stimulation of the Retina Reduces Bruch's Membrane Thickness in Age Related Macular Degeneration Mouse Models. Transl Vis Sci Technol. 2018; 7(3):2. PMC: 5931258. DOI: 10.1167/tvst.7.3.2. View

Micera A, Stampachiacchiere B, Aronni S, Dos Santos M, Lambiase A . Toll-like receptors and the eye. Curr Opin Allergy Clin Immunol. 2005; 5(5):451-8. DOI: 10.1097/01.all.0000182537.55650.99. View

Zhao Z, Chen Y, Wang J, Sternberg P, Freeman M, Grossniklaus H . Age-related retinopathy in NRF2-deficient mice. PLoS One. 2011; 6(4):e19456. PMC: 3084871. DOI: 10.1371/journal.pone.0019456. View

Shiose S, Chen Y, Okano K, Roy S, Kohno H, Tang J . Toll-like receptor 3 is required for development of retinopathy caused by impaired all-trans-retinal clearance in mice. J Biol Chem. 2011; 286(17):15543-55. PMC: 3083179. DOI: 10.1074/jbc.M111.228551. View

Maloney S, Antecka E, Orellana M, Fernandes B, Odashiro A, Eghtedari M . Choroidal neovascular membranes express toll-like receptor 3. Ophthalmic Res. 2010; 44(4):237-41. DOI: 10.1159/000313989. View

Datta S, Cano M, Ebrahimi K, Wang L, Handa J . The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res. 2017; 60:201-218. PMC: 5600827. DOI: 10.1016/j.preteyeres.2017.03.002. View

10.

Kumar A, Yu F . Toll-like receptors and corneal innate immunity. Curr Mol Med. 2006; 6(3):327-37. PMC: 2666391. DOI: 10.2174/156652406776894572. View

11.

Chen C, Guo D, Lu G . Wogonin protects human retinal pigment epithelium cells from LPS-induced barrier dysfunction and inflammatory responses by regulating the TLR4/NF-κB signaling pathway. Mol Med Rep. 2017; 15(4):2289-2295. DOI: 10.3892/mmr.2017.6252. View

12.

Duncan R, Rohowetz L, Vogt A, Koulen P . Repeat exposure to polyinosinic:polycytidylic acid induces TLR3 expression via JAK-STAT signaling and synergistically potentiates NFκB-RelA signaling in ARPE-19 cells. Cell Signal. 2019; 66:109494. DOI: 10.1016/j.cellsig.2019.109494. View

13.

Zhu Y, Dai B, Li Y, Peng H . C5a and toll-like receptor 4 crosstalk in retinal pigment epithelial cells. Mol Vis. 2015; 21:1122-9. PMC: 4588711. View

14.

Zamiri P, Masli S, Kitaichi N, Taylor A, Wayne Streilein J . Thrombospondin plays a vital role in the immune privilege of the eye. Invest Ophthalmol Vis Sci. 2005; 46(3):908-19. DOI: 10.1167/iovs.04-0362. View

15.

Bonini S, Micera A, Iovieno A, Lambiase A, Bonini S . Expression of Toll-like receptors in healthy and allergic conjunctiva. Ophthalmology. 2005; 112(9):1528. DOI: 10.1016/j.ophtha.2005.04.009. View

16.

Kleinman M, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi J . Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature. 2008; 452(7187):591-7. PMC: 2642938. DOI: 10.1038/nature06765. View

17.

Edwards A, Chen D, Fridley B, James K, Wu Y, Abecasis G . Toll-like receptor polymorphisms and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008; 49(4):1652-9. DOI: 10.1167/iovs.07-1378. View

18.

Yang Z, Stratton C, Francis P, Kleinman M, Tan P, Gibbs D . Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med. 2008; 359(14):1456-63. PMC: 2573951. DOI: 10.1056/NEJMoa0802437. View

19.

Sng C, Cackett P, Yeo I, Thalamuthu A, Venkatraman A, Venkataraman D . Toll-like receptor 3 polymorphism rs3775291 is not associated with choroidal neovascularization or polypoidal choroidal vasculopathy in Chinese subjects. Ophthalmic Res. 2010; 45(4):191-6. DOI: 10.1159/000321387. View

20.

Liew G, Mitchell P, Wong T . Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med. 2009; 360(21):2252. View